drugset / Trial / NCT03775629

Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers

NCT03775629

Phase 1 Completed 41 enrolled CrystalGenomics, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized, open-label, multiple-dose, parallel, Phase 1 study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG100650" in healthy volunteers.

Timeline

Start
2018-12-01
Primary completion
2019-04-04
Completion
2019-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Polmacoxib Other / unclassified
Comparator Tramadol Other / unclassified

Indications

No indication recorded.